The deletion of ACSL4 gene confers resistance to ferroptosis in PC3 and DU145 cells [43], suggesting that ACSL4 gene expression level might be a proxy in predicting sensitivity to ferroptosis in prostate cancer cells. This evidence concerns the gene ACSL4 and Familial prostate cancer.